AKRO logo

Akero Therapeutics (AKRO) return on equity

annual ROE:

-33.60%-5.25%(-18.52%)
December 31, 2024

Summary

  • As of today (July 1, 2025), AKRO annual return on equity is -33.60%, with the most recent change of -5.25% (-18.52%) on December 31, 2024.
  • During the last 3 years, AKRO annual ROE has risen by +25.99% (+43.61%).
  • AKRO annual ROE is now -120.53% below its all-time high of 163.69%, reached on December 31, 2018.

Performance

AKRO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROprofitability metrics

quarterly ROE:

-31.98%+0.20%(+0.62%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AKRO quarterly return on equity is -31.98%, with the most recent change of +0.20% (+0.62%) on March 31, 2025.
  • Over the past year, AKRO quarterly ROE has dropped by -4.20% (-15.12%).
  • AKRO quarterly ROE is now -119.54% below its all-time high of 163.69%, reached on December 31, 2018.

Performance

AKRO quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

AKRO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-18.5%-15.1%
3 y3 years+43.6%+47.4%
5 y5 years+1.1%+12.7%

AKRO ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.5%+43.6%-22.5%+51.9%
5 y5-year-18.5%+43.6%-22.5%+51.9%
alltimeall time-120.5%+43.6%-119.5%+96.4%

AKRO ROE History

DateAnnualQuarterly
Mar 2025
-
-31.98%(-0.6%)
Dec 2024
-33.60%(+18.5%)
-32.18%(-1.0%)
Sep 2024
-
-32.52%(+10.0%)
Jun 2024
-
-29.56%(+6.4%)
Mar 2024
-
-27.78%(-6.6%)
Dec 2023
-28.35%(-17.4%)
-29.74%(+13.9%)
Sep 2023
-
-26.11%(-10.0%)
Jun 2023
-
-29.01%(-27.1%)
Mar 2023
-
-39.77%(-14.4%)
Dec 2022
-34.31%(-42.4%)
-46.44%(-22.8%)
Sep 2022
-
-60.13%(-9.6%)
Jun 2022
-
-66.51%(+9.3%)
Mar 2022
-
-60.85%(+25.9%)
DateAnnualQuarterly
Dec 2021
-59.59%(+94.6%)
-48.34%(+13.8%)
Sep 2021
-
-42.48%(+12.9%)
Jun 2021
-
-37.63%(+2.1%)
Mar 2021
-
-36.84%(-10.8%)
Dec 2020
-30.62%(-9.9%)
-41.30%(+1.1%)
Sep 2020
-
-40.87%(-14.8%)
Jun 2020
-
-47.97%(+30.9%)
Mar 2020
-
-36.65%(+4.7%)
Dec 2019
-33.99%(-120.8%)
-34.99%(-68.6%)
Sep 2019
-
-111.49%(-22.3%)
Jun 2019
-
-143.51%(-83.7%)
Mar 2019
-
-877.83%(-636.3%)
Dec 2018
163.69%
163.69%

FAQ

  • What is Akero Therapeutics annual return on equity?
  • What is the all time high annual ROE for Akero Therapeutics?
  • What is Akero Therapeutics annual ROE year-on-year change?
  • What is Akero Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Akero Therapeutics?
  • What is Akero Therapeutics quarterly ROE year-on-year change?

What is Akero Therapeutics annual return on equity?

The current annual ROE of AKRO is -33.60%

What is the all time high annual ROE for Akero Therapeutics?

Akero Therapeutics all-time high annual return on equity is 163.69%

What is Akero Therapeutics annual ROE year-on-year change?

Over the past year, AKRO annual return on equity has changed by -5.25% (-18.52%)

What is Akero Therapeutics quarterly return on equity?

The current quarterly ROE of AKRO is -31.98%

What is the all time high quarterly ROE for Akero Therapeutics?

Akero Therapeutics all-time high quarterly return on equity is 163.69%

What is Akero Therapeutics quarterly ROE year-on-year change?

Over the past year, AKRO quarterly return on equity has changed by -4.20% (-15.12%)
On this page